9-76709825-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015225.3(PRUNE2):​c.2449A>G​(p.Asn817Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.571 in 1,613,244 control chromosomes in the GnomAD database, including 267,173 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 21642 hom., cov: 31)
Exomes 𝑓: 0.58 ( 245531 hom. )

Consequence

PRUNE2
NM_015225.3 missense

Scores

2
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.28

Publications

29 publications found
Variant links:
Genes affected
PRUNE2 (HGNC:25209): (prune homolog 2 with BCH domain) The protein encoded by this gene belongs to the B-cell CLL/lymphoma 2 and adenovirus E1B 19 kDa interacting family, whose members play roles in many cellular processes including apotosis, cell transformation, and synaptic function. Several functions for this protein have been demonstrated including suppression of Ras homolog family member A activity, which results in reduced stress fiber formation and suppression of oncogenic cellular transformation. A high molecular weight isoform of this protein has also been shown to colocalize with Adaptor protein complex 2, beta-Adaptin and endodermal markers, suggesting an involvement in post-endocytic trafficking. In prostate cancer cells, this gene acts as a tumor suppressor and its expression is regulated by prostate cancer antigen 3, a non-protein coding gene on the opposite DNA strand in an intron of this gene. Prostate cancer antigen 3 regulates levels of this gene through formation of a double-stranded RNA that undergoes adenosine deaminase actin on RNA-dependent adenosine-to-inosine RNA editing. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
PCA3 (HGNC:8637): (prostate cancer associated 3) This gene produces a spliced, long non-coding RNA that is highly overexpressed in most types of prostate cancer cells and is used as a specific biomarker for this type of cancer. This gene is embedded in an intronic region of the prune2 gene on the opposite DNA strand. The transcript regulates prune2 levels through formation of a double-stranded RNA that undergoes adenosine deaminase acting on RNA-dependent adenosine-to-inosine RNA editing. In prostate cancer derived cells, overexpression of PCA induced downregulation of prune2, leading to decreased cell proliferation. Conversely, silencing in prostate cancer cells resulted in increased proliferation. Regulation of this gene appears to be sensitive to androgen-receptor activation, a molecular signature of prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.0732673E-6).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRUNE2NM_015225.3 linkc.2449A>G p.Asn817Asp missense_variant Exon 8 of 19 ENST00000376718.8 NP_056040.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRUNE2ENST00000376718.8 linkc.2449A>G p.Asn817Asp missense_variant Exon 8 of 19 5 NM_015225.3 ENSP00000365908.3

Frequencies

GnomAD3 genomes
AF:
0.521
AC:
79013
AN:
151760
Hom.:
21634
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.400
Gnomad AMR
AF:
0.644
Gnomad ASJ
AF:
0.706
Gnomad EAS
AF:
0.367
Gnomad SAS
AF:
0.532
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.703
Gnomad NFE
AF:
0.593
Gnomad OTH
AF:
0.591
GnomAD2 exomes
AF:
0.570
AC:
141338
AN:
248070
AF XY:
0.573
show subpopulations
Gnomad AFR exome
AF:
0.346
Gnomad AMR exome
AF:
0.697
Gnomad ASJ exome
AF:
0.697
Gnomad EAS exome
AF:
0.370
Gnomad FIN exome
AF:
0.513
Gnomad NFE exome
AF:
0.599
Gnomad OTH exome
AF:
0.603
GnomAD4 exome
AF:
0.576
AC:
842119
AN:
1461366
Hom.:
245531
Cov.:
61
AF XY:
0.577
AC XY:
419307
AN XY:
726946
show subpopulations
African (AFR)
AF:
0.349
AC:
11691
AN:
33476
American (AMR)
AF:
0.687
AC:
30696
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.695
AC:
18168
AN:
26132
East Asian (EAS)
AF:
0.379
AC:
15033
AN:
39690
South Asian (SAS)
AF:
0.543
AC:
46867
AN:
86246
European-Finnish (FIN)
AF:
0.515
AC:
27514
AN:
53376
Middle Eastern (MID)
AF:
0.712
AC:
4108
AN:
5766
European-Non Finnish (NFE)
AF:
0.588
AC:
653350
AN:
1111636
Other (OTH)
AF:
0.575
AC:
34692
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
21850
43700
65550
87400
109250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17820
35640
53460
71280
89100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.521
AC:
79057
AN:
151878
Hom.:
21642
Cov.:
31
AF XY:
0.520
AC XY:
38592
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.356
AC:
14739
AN:
41404
American (AMR)
AF:
0.643
AC:
9820
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
2447
AN:
3468
East Asian (EAS)
AF:
0.367
AC:
1887
AN:
5138
South Asian (SAS)
AF:
0.535
AC:
2576
AN:
4814
European-Finnish (FIN)
AF:
0.518
AC:
5461
AN:
10542
Middle Eastern (MID)
AF:
0.697
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
0.593
AC:
40316
AN:
67930
Other (OTH)
AF:
0.589
AC:
1241
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1857
3715
5572
7430
9287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.571
Hom.:
62092
Bravo
AF:
0.522
TwinsUK
AF:
0.584
AC:
2165
ALSPAC
AF:
0.590
AC:
2273
ESP6500AA
AF:
0.369
AC:
1156
ESP6500EA
AF:
0.605
AC:
4333
ExAC
AF:
0.561
AC:
67507
Asia WGS
AF:
0.449
AC:
1559
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.020
T;T;T
Eigen
Benign
-0.10
Eigen_PC
Benign
0.039
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.55
T;T;T
MetaRNN
Benign
0.0000061
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.8
L;.;.
PhyloP100
1.3
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.4
N;.;N
REVEL
Benign
0.073
Sift
Benign
0.041
D;.;D
Sift4G
Benign
0.16
T;T;T
Polyphen
0.38
B;.;.
Vest4
0.37
MPC
0.12
ClinPred
0.013
T
GERP RS
5.7
PromoterAI
-0.0062
Neutral
Varity_R
0.16
gMVP
0.28
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs557352; hg19: chr9-79324741; COSMIC: COSV65038637; API